Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PDPK1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PDPK1 mRNA | affects expression | 21346803
|
C518576 |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate results in decreased expression of PDPK1 mRNA | decreases expression | 17327690
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of PDPK1 mRNA | affects expression | 18648102
|
C054852 |
7-hydroxystaurosporine |
7-hydroxystaurosporine results in decreased activity of PDPK1 protein | decreases activity | 16178010
|
D000584 |
Amiloride |
Amiloride results in decreased phosphorylation of PDPK1 protein | decreases phosphorylation | 16059913
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PDPK1 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased activity of PDPK1 protein | decreases activity | 14633726
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PDPK1 mRNA | decreases expression | 19150397
|
C105934 |
celecoxib |
celecoxib results in decreased activity of PDPK1 protein | decreases activity | 16178010
|
D004317 |
Doxorubicin |
PDPK1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 16782806
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of PDPK1 protein | decreases expression | 19429709
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of PDPK1 mRNA | affects cotreatment|decreases expression | 17404688
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PDPK1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDPK1 mRNA | affects cotreatment|increases expression | 17942748
|
C056507 |
gemcitabine |
PDPK1 protein modified form results in decreased susceptibility to gemcitabine | decreases response to substance | 16782806
|
D017239 |
Paclitaxel |
PDPK1 protein results in decreased susceptibility to Paclitaxel | decreases response to substance | 16782806
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PDPK1 mRNA | increases expression | 18301758
|
C025299 |
polyphenols |
polyphenols results in decreased expression of PDPK1 mRNA | decreases expression | 16293270
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of PDPK1 mRNA | affects cotreatment|decreases expression | 17404688
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of PDPK1 protein] | decreases reaction|increases phosphorylation | 16343977
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA | affects cotreatment|decreases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDPK1 mRNA | affects cotreatment|increases expression | 17942748
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL1B protein results in increased phosphorylation of PDPK1 protein] | decreases reaction|increases phosphorylation | 17136479
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone results in decreased activity of PDPK1 protein | decreases activity | 17136479
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone results in decreased activity of PDPK1 protein | decreases activity | 16178010
|
D014638 |
Vanadates |
Vanadates results in increased expression of PDPK1 protein | increases expression | 17874149
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of PDPK1 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.68 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.39 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.77 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.70 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.96 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.81 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.81 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.81 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.81 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.51 | 3712494 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.51 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.33 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.33 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
celecoxib |
4.93 | 16215675 19003578 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.38 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.53 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.80 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.29 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.90 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
11.90 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
11.90 | 18706406 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.17 | 16873680 17967414 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.85 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
14.37 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.37 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.62 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.65 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.53 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.41 | 15867366 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.17 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.09 | 15380490 15845082 15665606 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.11 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.66 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
3.66 | 17426702 16264153 15994142 15993339 11325840 16322301 18628466 15136595 17983394 15939500 18382427 18695136 16115903 16595493 16935488 19526202 15668708 16826403 15567936 16096432 17369602 15634643 18234424 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.66 | 17289903 16675129 17261762 12948864 14630087 17018787 18497071 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
3.66 | 17039268 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
3.66 | 11325840 18234424 16115903 18323546 16244791 16273361 18223236 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.66 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
3.66 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.66 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.17 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.29 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.76 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.64 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.66 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
16.45 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
16.45 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
16.45 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
16.45 | 14691202 15073043 15553829 16217749 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
16.45 | 16023760 17876044 16234567 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
16.45 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
16.45 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
16.45 | 19321006 16227395 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.42 | 16675471 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.70 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
10.48 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
celecoxib |
10.48 | 16369983 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.48 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.97 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.77 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
4.77 | 16227395 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Amiloride |
4.93 | 14644129 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.27 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.42 | 15476868 15792986 15811867 16731534 17329180 17519947 17974986 18627295 17007740 16269455 17924179 16651473 17308081 17351982 16455267 16364871 17382496 17131338 16612575 15505089 16242529 16109756 16278810 17928571 16952015 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.89 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.36 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.05 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.05 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.05 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.05 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.64 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.64 | 15861022 16105132 17110522 17681005 17333356 16919318 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.64 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 8697196 16354765 12621046 15668235 15340226 |
MESH:D003092 |
Colitis |
|
Amiloride |
15.25 | 12065299 |
MESH:D003092 |
Colitis |
|
resveratrol |
15.25 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
15.25 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
celecoxib |
5.92 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
5.92 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.92 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
6.33 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
celecoxib |
6.33 | 18349538 11197048 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
6.33 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
6.33 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
6.33 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.64 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.02 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.66 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.66 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.33 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.33 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.93 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.64 | 18759878 2524372 12868966 11906362 11298694 8156756 14531868 8970840 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.35 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.33 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.63 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.53 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.53 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.32 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
17.90 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
17.90 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
17.90 | 8291058 1440618 18289764 16192314 18648102 6679447 9653073 9022650 18692083 7440962 6482804 9328219 11289319 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
17.90 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
17.90 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
17.90 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.90 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.69 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.69 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.53 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.53 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
10.53 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.53 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.73 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.43 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
14.43 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
14.43 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.17 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.17 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
celecoxib |
14.54 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
14.54 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
14.54 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.98 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.68 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.05 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.05 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
10.05 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
10.05 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.89 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
12.15 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.15 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.15 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.29 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.85 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.42 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.78 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.10 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.24 | 17150277 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.88 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.42 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Amiloride |
4.64 | 19703807 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.41 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.27 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.27 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.37 | 16244372 17888722 16495754 16879835 18006777 16144979 17875725 12587719 14766674 16330681 16244371 16707910 18674790 |
MESH:D006333 |
Heart Failure |
marker/mechanism |
|
| 19429709 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
11.20 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
11.20 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
11.20 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.74 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.18 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.35 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.70 | 19772884 19176532 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.70 | 12621046 16120746 15340226 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.64 | 16863852 16490937 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.86 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.01 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.27 | 15147373 17606976 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.47 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
9.47 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.87 | 16354765 18606429 16959395 8697196 15340226 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.85 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.03 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.87 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.77 | 15034207 |
MESH:D006973 |
Hypertension |
|
Amiloride |
5.38 | 18524855 19344079 15174897 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.38 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.15 | 17488730 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Amiloride |
5.68 | 19822448 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.64 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.92 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.92 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.30 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.37 | 17937319 |
MESH:D007249 |
Inflammation |
|
Amiloride |
14.96 | 17237260 |
MESH:D007249 |
Inflammation |
|
polyphenols |
14.96 | 16366677 |
MESH:D007249 |
Inflammation |
|
Progesterone |
14.96 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
14.96 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.96 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
17.63 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
17.63 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
17.63 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.83 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.83 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.85 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.58 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.58 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
9.58 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.46 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
9.46 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.60 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
16.60 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.60 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
16.60 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.75 | 15070760 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.98 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.64 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.13 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.30 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.60 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.11 | 16467208 16968895 20471514 19850784 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.42 | 19225113 15622746 9834237 12712474 16891316 19642359 17107899 17712046 11468182 17217047 17649720 12679006 15213294 16331271 11161223 15748426 19075265 17869043 16823087 15336539 16966277 12018890 19035177 16330433 16112521 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.42 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.19 | 16882451 |
MESH:D056929 |
Liddle Syndrome |
|
Amiloride |
5.80 | 19344079 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.66 | 17353645 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.09 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.50 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.50 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.50 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.50 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
6.50 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.74 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
13.54 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
13.54 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.54 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.54 | 19812893 19073162 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.54 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
17.52 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.52 | 1399818 3712494 598648 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
17.52 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
17.52 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.52 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.22 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.06 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
4.69 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.69 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.69 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
4.69 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.34 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.14 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
13.82 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
13.82 | 14749477 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
13.82 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.40 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.07 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
celecoxib |
22.17 | 19196722 12104042 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
22.17 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
22.17 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
22.17 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
22.17 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
22.17 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.31 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.10 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
5.10 | 12040289 12025231 16342250 |
MESH:D008545 |
Melanoma |
|
resveratrol |
5.10 | 17992120 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.06 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.06 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.22 | 17112576 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.34 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.62 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
16.36 | 19549372 14977855 11468182 19417148 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
celecoxib |
16.36 | 16123214 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
16.36 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
16.36 | 17935668 16490592 16267019 17049120 14749477 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.70 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.34 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.50 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.05 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.10 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.10 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.10 | 16525036 16456233 17188708 16317513 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.56 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.56 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.81 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.81 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.59 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.77 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.77 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Amiloride |
10.11 | 14644129 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
10.11 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.21 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.21 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
9.21 | 15867366 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.87 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.83 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
celecoxib |
5.26 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.56 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.60 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.85 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.91 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.91 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.88 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
6.88 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.18 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.67 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.24 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.77 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
14.19 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
14.19 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
14.19 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.85 | 3988306 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.81 | 15867366 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.09 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.98 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
10.88 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.88 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
10.88 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.88 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.48 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
5.48 | 17440100 18383843 11504793 16929163 18992248 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.53 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.31 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.00 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.08 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.30 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.98 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.72 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.98 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.39 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.02 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.02 | 11399792 11896295 11118676 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.73 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.08 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
celecoxib |
2.08 | 15570007 17908994 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.08 | 15897917 16729912 16868541 15749863 16888761 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.08 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.08 | 17136230 16729912 17172428 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.08 | 17675339 17636462 16731767 17804756 17718901 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.08 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.14 | 16919318 15861022 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.05 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.41 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.29 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.29 | 17520802 17058453 16314181 15827377 16317513 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.67 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.25 | 3692021 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.80 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.84 | 17203757 17710206 16767912 15675481 18313854 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
9.72 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.72 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.62 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.48 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.48 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.40 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.06 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
9.06 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.06 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.40 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.77 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.11 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.55 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
celecoxib |
3.55 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.55 | 18396642 18506536 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.38 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.33 | 16321402 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.64 | 16930453 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.08 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.46 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.01 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.73 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.26 | 1399818 6582329 3712494 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
11.26 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.26 | 17909728 16010429 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.51 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.06 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.79 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
15.09 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.09 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.09 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
15.09 | 12973940 20435036 11780464 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
15.09 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.41 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.41 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
3.95 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
celecoxib |
15.25 | 18645019 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
15.25 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
15.25 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.42 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.38 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
9.77 | 17638931 17334414 16364871 17678736 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
9.77 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.08 | 15886252 |